
Align Technology, Inc. (ALGN) gains despite earnings misses
Align Technology, Inc. (ALGN) gains 1.5% even after earnings misses, as investors weigh the latest results against the stock’s recent momentum.
Everything tagged "medical devices" across research, earnings, and macro.
16 articles

Align Technology, Inc. (ALGN) gains 1.5% even after earnings misses, as investors weigh the latest results against the stock’s recent momentum.

GE HealthCare offers a balanced medtech setup with a $21.8B backlog, growing pharmaceutical diagnostics, and solid free cash flow, but tariffs and margin pressure are still weighing on results.

Intuitive Surgical is still compounding through mid-teens procedure growth, rising da Vinci 5 adoption, and a highly recurring revenue mix. The stock looks like a quality-growth name with strong execution, but valuation remains rich.

Abbott Laboratories is a diversified healthcare compounder with improving growth across medical devices, diagnostics, nutrition, and emerging-market pharmaceuticals. The stock looks high quality but fairly valued, making it more attractive on pullbacks than at current levels.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator